John B. Buse, M.D., Ph.D. is the Verne S. Caviness Distinguished Professor of Medicine, Director of the Diabetes Care Center, Chief of the Division of Endocrinology and Executive Associate Dean of Clinical research at UNC, where he is the principal investigator on numerous studies in the prevention and treatment of type 1 and type 2 diabetes mellitus. Dr. Buse served as President of Medicine and Science for the American Diabetes Association in 2008, and in 2011 he was appointed as Chair of the National Diabetes Education Program. Dr. Buse has authored more than 200 publications and received numerous awards and honors.

Vivian A. Fonseca, M.D., F.R.C.P. is Professor of Medicine and Alumni Chair in Diabetes in the Section of Endocrinology, at Tulane University’s Health Sciences Center. He is the principal investigator of the DRMS (diabetes remote management system) study, which is designed to evaluate the effectiveness and possibilities of using a remote technology system to enhance and manage daily care for patients with type 2 diabetes. Dr. Fonseca has conducted trials for most diabetes drugs on the market. A former President of Medicine and Science for the American Diabetes Association, he is editor-in-chief of the Journal of Diabetes Complications and has served as editor-in-chief of Diabetes Care and the Journal of the Metabolic Syndrome and Related Disorders.

Richard A. Kahn, Ph.D. is an independent consultant/researcher and clinical professor of medicine at the University of North Carolina School of Medicine. A senior staff member of the American Diabetes Association from 1985 until his retirement from the Association in 2009, Dr. Kahn was the Chief Scientific and Medical Officer and was responsible for all the scientific and medical affairs of the Association. Dr. Kahn established the first tissue bank in the Red Cross System and directed a large research laboratory concerned with the pathophysiology of blood cells and the prevention of transfusion-transmitted diseases.

Dr. Stanley Hsia is an Associate Professor of Medicine at Charles R. Drew University of Medicine and Science, and a Health Sciences Associate Clinical Professor at the David Geffen School of Medicine at UCLA, Los Angeles, CA. He completed his medical school at the University of Toronto, Canada, Internal Medicine residency at Queen’s University, Endocrinology Fellowship at the University of Toronto, and did postdoctoral research at the University of California, San Diego. He is certified in Endocrinology & Metabolism by both the American Board of Internal Medicine and the Royal College of Physicians and Surgeons of Canada, and is a Fellow of the American College of Endocrinology as well as a Diplomate of the American Board of Clinical Lipidology. He currently teaches in the Charles R. Drew University-UCLA medicine program, serves as a Clinical Trials Principal Investigator with the National Research Institute (NRI) in Los Angeles and Santa Ana, CA, and practices as a clinical endocrinologist with the Southern California Endocrine Group in Orange, CA. His academic interests focus on insulin resistance and its related conditions, including obesity, diabetes, and dyslipidemia. He has received research grants from the NIH and the American Diabetes Association, and has published numerous original research studies, review articles, CME programs, and book chapters, as well as presenting his research at numerous national and international meetings.